The peptide activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation in a dose-dependent manner, leading to nuclear translocation and activation of transcription factors including c-Fos, c-Jun, and early growth response-1 (Egr-1) that drive expression of genes involved in cell growth, migration, and angiogenesis
Toxicol Appl Pharmacol 1989;101:356-69
Real-world practitioners often experiment with dose reduction once patients reach their goal weight
I spent months immersed in Attias ideas, including his book, podcast, newsletter, and the Early program
References Frohman LA, Downs TR, Chomczynski P
Retrieved May 24, 2012